ENTITY
Transcenta Holding

Transcenta Holding (6628 HK)

11
Analysis
Health Care • China
Transcenta Holding Limited operates as a global biotherapeutics company. The Company develops therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Transcenta Holding provides services in China.
more
bullish•Biel Crystal
•19 Sep 2021 10:10

ECM Weekly (19th September 2021) - PHC, StarHealth, TDCX, Biel Crystal, DRCBank, Transcenta, Broncus

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
527 Views
Share
bearish•Transcenta Holding
•15 Sep 2021 21:17

Transcenta (åˆ›čƒœ) IPO: Fairly Valued Despite Downsizing

We provide an update of the deal terms and the valuation for the Transcenta's book building. We think the deal is fairly valued despite its...

Logo
409 Views
Share
bearish•Transcenta Holding
•22 Jul 2021 09:09

Pre-IPO Transcenta Holding -Ā Insights on Pipeline and the Concerns

The article mainly analyzed Transcenta Holding in terms of its important product candidates MSB2311,Ā TST001, TST005 and MSB0254,including the...

Logo
337 Views
Share
bullish•Transcenta Holding
•19 Jul 2021 09:36

Transcenta (åˆ›čƒœ) Pre-IPO: Thoughts on Valuation

We provide a pre-money valuation for Transcenta's key products, including MSB2311 (next generation PD-L1) and TST001 (Claudin 18.2) in this note.

Logo
481 Views
Share
bullish•Full Truck Alliance
•04 Jul 2021 10:21

ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x